# Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

> **NCT00725543** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 358 (actual)

## Conditions studied

- Spondylitis, Ankylosing

## Interventions

- **BIOLOGICAL:** Infliximab

## Key facts

- **NCT ID:** NCT00725543
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2015-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725543, "Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00725543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*